AS

Albert Saha

Active Director Director DIN 08271285
DIN 08271285 First appointment Oct 2018 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Oct 2018
Shareholding value Locked Premium profile

About Albert Saha

Albert Saha has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Medrain Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08271285
Primary Designation Director
First Appointment 31 Oct 2018
Oldest Company Age 9 yrs

Current companies

Company Designation Appointment Founded Status
Director 31 Oct 2018 2017 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medrain Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Albert Saha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Albert Saha

Albert Saha has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Medrain Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Albert Saha is associated with 1 company as Director.

Albert Saha has expertise in General Business.

Albert Saha has 7 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available